To determine if MDM2 contributes to drug resistance in glioma, one study inhibited the expression of MDM2 genetically using siRNA or chemically using the MDM2 inhibitor RG7112 in U87 and DK-MG cells [144]. This evidence concerns the gene MDM2 and central nervous system cancer.